Role of hypoxia in cancer therapy by regulating the tumor microenvironment

X Jing, F Yang, C Shao, K Wei, M Xie, H Shen, Y Shu - Molecular cancer, 2019 - Springer
Aim Clinical resistance is a complex phenomenon in major human cancers involving
multifactorial mechanisms, and hypoxia is one of the key components that affect the cellular …

Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health

PJ O'Brien, AG Siraki, N Shangari - Critical reviews in toxicology, 2005 - Taylor & Francis
Aldehydes are organic compounds that are widespread in nature. They can be formed
endogenously by lipid peroxidation (LPO), carbohydrate or metabolism ascorbate …

Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease

PJ Thornalley - Drug metabolism and drug interactions, 2008 - degruyter.com
Glycation of proteins, nucleotides and basic phospholipids by glyoxal and methylglyoxal-
physiological substrates of glyoxalase 1-iso potentially damaging to the proteome, genome …

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal

T Tsuruo, M Naito, A Tomida, N Fujita… - Cancer …, 2003 - Wiley Online Library
Recent progress in the development of molecular cancer therapeutics has revealed new
types of antitumor drugs, such as Herceptin, Gleevec, and Iressa, as potent therapeutics for …

Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics

N Rabbani, M Xue, PJ Thornalley - Glycoconjugate journal, 2016 - Springer
The reactive dicarbonyl metabolite methylglyoxal (MG) is the precursor of the major
quantitative advanced glycation endproducts (AGEs) in physiological systems-arginine …

Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments

N Rabbani, M Xue, PJ Thornalley - Clinical science, 2016 - portlandpress.com
Dicarbonyl stress is the abnormal accumulation of dicarbonyl metabolites leading to
increased protein and DNA modification contributing to cell and tissue dysfunction in aging …

Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer

DH Zhang, LK Tai, LL Wong, LL Chiu, SK Sethi… - Molecular & Cellular …, 2005 - ASBMB
The receptor tyrosine kinase ErbB2 (HER-2/neu) is overexpressed in up to 30% of breast
cancers and is associated with poor prognosis and an increased likelihood of metastasis …

Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats

O Brouwers, PM Niessen, I Ferreira, T Miyata… - Journal of Biological …, 2011 - ASBMB
The reactive advanced glycation end product (AGE) precursor methylglyoxal (MGO) and
MGO-derived AGEs are associated with diabetic vascular complications and also with an …

Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer

MB Jones, H Krutzsch, H Shu, Y Zhao… - PROTEOMICS …, 2002 - Wiley Online Library
Epithelial ovarian cancer kills almost 16 000 women each year in part due to late stage of
presentation and lack of reliable biomarkers for disease detection. CA‐125, the currently …